Vir Biotechnology (VIR) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Circular Climate Change Environment Environmental Extreme Weather Forestry Life Cycle Lifecycle Materials Nature Nuclear Offset Package Packaging Pandemic Raw Materials Recycling Renewable Waste Water Wind Access African American Asian Benefits Black California Consumer Privacy Act Charitable Community Culture Customer Cyber Cyber Security Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Drug Pricing Employee Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury Latinx LGBTQ Minority Opioid Perquisites Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skilled Skills Social Society Supplier Supply Chain Talent Training Union Volunteer Women Workers Workforce Action Plan Anti-corruption Antitrust Assessment Assurance Attorney General Attorneys General Audit Board Refreshment Bonus Bribery Chronic Classified Clawback Commitment Conflict of Interest Corporate Governance Corruption Department of ESG Ethics Executive Compensation Expert Fined Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Perquisite Plaintiff Pledging Procurement Proxy Access Purpose R&D Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Self-evaluation Stockholder Engagement Strategy Sustainability Sustainable Targets Tax Tax Gross Up Tenure Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 19, 2023, Vir Biotechnology, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). As of March 30, 2023, the record date for the Annual Meeting, 133,930,936 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below.
Proposal 1. Election of Directors
The Company’s stockholders elected the four persons listed below as Class I Directors, each to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows:

	Votes For	Votes Withheld	Broker Non-Votes


Robert More	109,608,096	897,767	8,334,036
Janet Napolitano	98,720,333	11,785,530	8,334,036
Vicki Sato, Ph.D.	98,355,146	12,150,717	8,334,036
Elliott Sigal, M.D., Ph.D.	109,721,001	784,862	8,334,036

Proposal 2. Advisory Vote on Executive Compensation
The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The final voting results are as follows:

Votes For	Votes Against	Abstentions	Broker Non-Votes


106,031,723	4,377,092	97,048	8,334,036

Proposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm
The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The final voting results are as follows:

Votes For	Votes Against	Abstentions	Broker Non-Votes


118,688,387	41,676	109,836	0